Free Trial

Humana (HUM) Stock Price, News & Analysis

Humana logo
$300.01 +5.54 (+1.88%)
Closing price 08/22/2025 03:59 PM Eastern
Extended Trading
$299.75 -0.26 (-0.09%)
As of 08/22/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Humana Stock (NYSE:HUM)

Key Stats

Today's Range
$295.90
$301.62
50-Day Range
$220.08
$300.01
52-Week Range
$206.87
$382.72
Volume
1.62 million shs
Average Volume
1.88 million shs
Market Capitalization
$36.08 billion
P/E Ratio
23.02
Dividend Yield
1.18%
Price Target
$283.29
Consensus Rating
Hold

Company Overview

Humana Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
84th Percentile Overall Score

HUM MarketRank™: 

Humana scored higher than 84% of companies evaluated by MarketBeat, and ranked 169th out of 937 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Humana has received a consensus rating of Hold. The company's average rating score is 2.30, and is based on 7 buy ratings, 16 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Humana has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Humana's stock forecast and price target.
  • Earnings Growth

    Earnings for Humana are expected to decrease by -20.28% in the coming year, from $16.47 to $13.13 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Humana is 23.02, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.44.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Humana is 23.02, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 31.36.

  • Price to Earnings Growth Ratio

    Humana has a PEG Ratio of 1.76. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Humana has a P/B Ratio of 1.97. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Humana's valuation and earnings.
  • Percentage of Shares Shorted

    3.90% of the float of Humana has been sold short.
  • Short Interest Ratio / Days to Cover

    Humana has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Humana has recently increased by 9.35%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Humana pays a meaningful dividend of 1.18%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Humana does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Humana is 27.17%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Humana will have a dividend payout ratio of 26.96% next year. This indicates that Humana will be able to sustain or increase its dividend.

  • Read more about Humana's dividend.
  • Percentage of Shares Shorted

    3.90% of the float of Humana has been sold short.
  • Short Interest Ratio / Days to Cover

    Humana has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Humana has recently increased by 9.35%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Humana has a news sentiment score of 1.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 42 news articles for Humana this week, compared to 28 articles on an average week.
  • Search Interest

    Only 28 people have searched for HUM on MarketBeat in the last 30 days. This is a decrease of -15% compared to the previous 30 days.
  • MarketBeat Follows

    Only 7 people have added Humana to their MarketBeat watchlist in the last 30 days. This is a decrease of -30% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Humana insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.37% of the stock of Humana is held by insiders.

  • Percentage Held by Institutions

    92.38% of the stock of Humana is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Humana's insider trading history.
Receive HUM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Humana and its competitors with MarketBeat's FREE daily newsletter.

HUM Stock News Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel
How the Cigna Deal Talks Are Shaping Humana’s 2025 Value Outlook
Humana declares $0.885 dividend
Humana Inc. stock outperforms competitors on strong trading day
See More Headlines

HUM Stock Analysis - Frequently Asked Questions

Humana's stock was trading at $253.71 at the beginning of the year. Since then, HUM stock has increased by 18.2% and is now trading at $300.0120.

Humana Inc. (NYSE:HUM) issued its quarterly earnings results on Wednesday, July, 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $6.32 by $0.05. The company's revenue was up 9.6% on a year-over-year basis.
Read the conference call transcript
.

Humana subsidiaries include these companies: Enclara Healthcare, Kindred Healthcare, American Eldercare, FPG, Metropolitan Health Networks, Certify Data Systems, Harris Rothenberg International, and others.

Humana's top institutional shareholders include Vanguard Group Inc. (11.81%), Dodge & Cox (9.44%), State Street Corp (4.47%) and Pzena Investment Management LLC (3.38%). Insiders that own company stock include Bruce D Broussard, David A Jr/Ky Jones, Timothy S Huval, Joseph C Ventura, Susan M Diamond, Jorge S Mesquita and William Kevin Fleming.
View institutional ownership trends
.

Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Humana investors own include Waste Connections (WCN), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), DiamondRock Hospitality (DRH), American Water Works (AWK), AU Optronics (AUOTY) and Triple Flag Precious Metals (TFPM).

Company Calendar

Record date for 7/25 Dividend
6/27/2025
Ex-Dividend for 7/25 Dividend
6/27/2025
Dividend Payable
7/25/2025
Last Earnings
7/30/2025
Today
8/24/2025
Next Earnings (Estimated)
10/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - HMO
Sub-Industry
Managed Health Care
Current Symbol
NYSE:HUM
CIK
49071
Employees
65,680
Year Founded
1961

Price Target and Rating

High Price Target
$344.00
Low Price Target
$250.00
Potential Upside/Downside
-5.6%
Consensus Rating
Hold
Rating Score (0-4)
2.30
Research Coverage
23 Analysts

Profitability

EPS (Trailing Twelve Months)
$13.03
Trailing P/E Ratio
23.02
Forward P/E Ratio
18.22
P/E Growth
1.76
Net Income
$1.21 billion
Net Margins
1.28%
Pretax Margin
1.80%
Return on Equity
13.67%
Return on Assets
4.85%

Debt

Debt-to-Equity Ratio
0.69
Current Ratio
1.95
Quick Ratio
1.95

Sales & Book Value

Annual Sales
$117.76 billion
Price / Sales
0.31
Cash Flow
$23.91 per share
Price / Cash Flow
12.55
Book Value
$152.11 per share
Price / Book
1.97

Miscellaneous

Outstanding Shares
120,270,000
Free Float
119,827,000
Market Cap
$36.08 billion
Optionable
Optionable
Beta
0.44

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NYSE:HUM) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners